Evaluation of novel nonlaser light source for endometrial ablation using 5-aminolevulinic acid

Lasers in Surgery and Medicine

Volumn 25, Issue 4, 1999, Pages 315-322

  Krzemien, Alicja A ^a   Van Vugt, Dean A ^a   Pottier, Roy H ^b   Dickson, Eva F ^b   Reid, Robert L ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b ROYAL MILITARY COLLEGE OF CANADA   (Canada)

Author keywords

Light sources; Noncoherent; Nonlaser; Photodynamic therapy; Uterus

Indexed keywords

AMINOLEVULINIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVICE; ENDOMETRIUM ABLATION; FEMALE; IRRADIATION; LIGHT EXPOSURE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; TISSUE NECROSIS;

AMINOLEVULINIC ACID; ANIMALS; DISEASE MODELS, ANIMAL; ENDOMETRIUM; FEMALE; LASERS; NECROSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; UTERINE DISEASES;

EID: 0032725296     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9101(1999)25:4<315::AID-LSM6>3.0.CO;2-N     Document Type: Article

References (38)

1. Photosensitizing compounds: their chemistry, biological and clinical use. In: Bock G, Harnet S, eds. Ciba Foundation Symposium 146. Chichester: John Wiley & Sons; 1989.
2. Kessel D, editor. Photodynamic therapy of neoplastic disease, vols I and II. Boca Raton: CRC Press; 1990.
3. Henderson BW, Dougherty TJ. How does the photodynamic therapy work? Photochem Photobiol 1992;55:145-147.
4. Ash DW, Brown SB. New drugs and future developments in photodynamic therapy. Eur J Cancer 1993;29A:1781-1783.
5. Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanism and clinical results. J Clin Laser Med Surg 1996;14:289-304.
6. Pottier RH, Kennedy JC. A new approach to photodynamic therapy: forcing the tumour to do most of the work. Biologija 1993;3:47-49.
7. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 1997;65:235-251.
8. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer 1997;79:2282-2308.
9. Roy BN, Van Vugt DA, Reid RL. Photodynamic therapy in gynaecology: bringing scientific discovery to the clinical area. J Soc Obstet Gynaecol Can 1997;19:709-719.
10. Stott PC. The outcome of menorrhagia: a retrospective case control study. J R Coll Gen Pract 1983;33:715-720.
11. Carlson KJ, Miller BA, Fowler FJ. The Main Women's Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol 1994;83:566-572.
12. Pokras R, Hufnagel VG. Hysterectomy in the United States 1965-1984. Am J Public Health 1988;78:852-853.
13. Copperman AB, DeCherney AH, Olive DL. A case of endometrial cancer following endometrial ablation for dysfunctional uterine bleeding. Obstet Gynecol 1993;82:640-642.
14. Loffer FD. Laser ablation of the endometrium. Obstet Gynecol Clin North Am 1988;15:77-89.
15. Whitehurst C, Byrne K, Moore JV. Development of an alternative light source to lasers for photodynamic therapy: 1. Comparative in vitro dose response characteristics. Lasers Med Sci 1993;8:259-267.
16. Whitehurst C, Humphries JD, Moore JV. Development of an alternative light source to lasers for photodynamic therapy: 2. Comparative in vivo tumour response characteristics. Lasers Med Sci 1995;10:121-126.
17. Morton, CA, Whitehurst C, Moseley H, Moore JV, Mackie RM. Development of an alternative light source to lasers for photodynamic therapy: 3. Clinical evaluation in the treatment of premalignant non-melanoma skin cancer. Lasers Med Sci 1995;10:165-171.
18. VERSA-LIGHT ONLINE. Haifa: Medic Lightech Led.; 1998. Available from: http://www.escmed.com
19. NOVACURE LIGHT ONLINE. Mississauga, ON, Canada: EFOS Canada Inc.; 1997.
20. Pottier RH, Dickson EF, Nadeau P, Wieland H, Sosin K, Kennedy JC. Assessment of non-coherent light sources for photodynamic therapy. SPIE 1994;2371:364-368.
21. Stringer MR. Problems associated with the use of broadband illumination sources for photodynamic therapy. Phys Med Biol 1995;40:1733-1734.
22. Roberts F, Whitehurst C, Moore JV, Stringer MR. Comments on "Problems associated with the use of broadband illumination sources for photodynamic therapy" [letter]. Phys Med Biol 1996;41:1517-1530.
23. Oriel Corp. Solar simulators for research and industry. Stratford, CT: Oriel Corp.; 1998.
24. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin. IX: Basic principles and present clinical experience. J Photochem Photobiol B Biol 1990;6:143-148.
25. Woff P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol 1993;28:17-21.
26. Wennberg AM, Lindholm LE, Alpsten M, Larko O. Treatment of superficial basal cell carcinomas using topically applied delta-aminolevulinic acid and a filtered xenon lamp. Arch Dermatol Res 1996;288:561-564.
27. Svaasand LO. Optical dosimetry for direct and interstitial photoradiation therapy of malignant tumors. In: Doiron D, Gomer CJ, editors. Porphyrin localization and treatment of tumors. New York: Alan R. Liss, Inc.; 1984. p 91-114.
28. Orenstein A, Kostenich G, Tsur H, Kogan L, Malik Z. Temperature monitoring during photodynamic therapy of skin tumours with topical 5-aminolevulinic acid application. Cancer Lett 1995;93:227-232.
29. Feritas I, Pontiggia P, Baronzio GF, McLaren JR. Perspectives for the combined use of photodynamic therapy and hyperthermia in cancer patient. Adv Exp Med Biol 1990;267:511-520.
30. Yang JZ, Van Vugt DA, Kennedy JC, Reid RL. Evidence of lasting functional destruction of the rat endometrium after 5-aminolevulinic acid-induced photodynamic ablation: prevention of implantation. Am J Obstet Gynecol 1993;168:995-1001.
31. Kennedy JC, Pottier RH. Using ALA in cancer therapy. In: Duke SO, Rebeiz CA, eds. Porphyric pesticides: chemistry, toxicology, and pharmaceutical applications. Washington, DC: American Chemical Society; 1994. p 291-302.
32. Moan J, Iani V, Ma LW. Choice of proper wavelength for photochemotherapy. SPIE 1996;2625:544-549.
33. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997;79:2282-2308.
34. König K, Schneckenburger H, Rück A, Steiner R. In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins. J Photochem Photobiol B Biol 1993;18:287-290.
35. Wyss P, Svaasand LO, Tadir Y, Haller U, Berns MW, Wyss MT, Tromberg BJ. Photomedicine of endometrium: experimental concepts. Hum Reprod 1995;10:221-226.
36. Wan S, Parrish JA, Anderson RR, Madden M. Transmittance of nonionizing radiation in human tissues. Photochem Photobiol 1981;34:679-681.
37. Wilson BC, Patrick Jeeves W, Lowe DM, Adam G. Light propagation in animal tissues in the wavelength range 375-825 nanometers. In: Doiron D, Gomer CJ, eds. Porphyrin localization and treatment of tumors. New York: Alan R. Liss, Inc.; 1984. p 115-132.
38. Fehr MK, Madsen SJ, Svaasand LO, Tromberg BJ, Eusebio J, Berns MW, Tadir Y. Intrauterine light delivery for photodynamic therapy of the human endometrium. Hum Reprod 1995;10:3067-3072.